Amineptine was never approved by the FDA for marketing in the United States where currently amineptine is off-patent and very difficult to obtain.
Currently amineptine is off-patent and very difficult to obtain. Amineptine was never approved by the FDA for marketing in the United States.
Amineptine was never approved by the FDA for marketing in the United States. Currently amineptine is off-patent and very difficult to obtain.
Amineptine was never approved by the FDA for marketing in the United States. Currently amineptine is off-patent and very difficult to obtain.